CONTEXTO | cottonbro | Pexels (CCO)
visits
–
The Modern biotech company vaccine against him covid-19 It could be launched later this year, the US government announced Monday, after the drug maker announced the start of phase 3 of the trial to demonstrate that it is safe and effective, the final hurdle before regulators approve it. global scale.
The trial is the first study of its kind to reach such an advanced stage under the Trump administration’s program, which seeks to accelerate the development of measures against the new coronavirus, adding to the hope that an effective vaccine help end the pandemic.
Moderna has received nearly a billion dollars from the United States government. The funds are helping to finance several possible vaccines.
More than 150 coronavirus vaccine candidates are in various stages of development. More than 20 prospects who have advanced to human testing.
“Having a safe and effective vaccine for distribution before the end of 2020 is a difficult goal, but it is the right goal for the American people.”, the director of the National Institutes of Health (NIH), Francis Collins, said in a statement.
Modern could have tens of millions of doses ready when and if the vaccine is considered safe and effective, Collins said.
Anthony Fauci, the country’s leading infectious disease expert, noted that conclusions about the effectiveness of what would be the first U.S. vaccine are likely to come in November or December.
“It is a world record for us to have been able to go from sequencing (of the SARS-CoV-2 virus) to phase 3 of a vaccine in such a short time. It has never been done before, ”explained Fauci, who also assured that the process, which has only taken about 6 months, has not compromised the scientific rigor or the safety of the trials.
–
–
